首页> 外文会议>International Conference on Applied Science and Technology >The relation between the RANKL and resistin in menopausal women with osteoporosis
【24h】

The relation between the RANKL and resistin in menopausal women with osteoporosis

机译:骨质疏松症绝经妇女中RANKL与抗性的关系

获取原文

摘要

Osteoporosis (OP) is osteometabolic disease characterized by a decrease in bone mineral density(BMD) and due to the deterioration of bone architecture leading to spontaneous fractures. The aim of the current study is to evaluate the biomarkers include the; receptor activator of nuclear factor NF-κB ligand and Resistin, also measuring the biochemical include: estrogen, calcium, phosphorus, bone mineral density, t-scores in menopausal women with osteoporosis, and further more study the correlation between these biomarkers and biochemical. Method : This study was conducted at DEXA (dual-energy x-ray absorptiometry) Unit in Radiology Department in Al-Sader teaching hospital in AL-Najaf province /Iraq from January2018 to July 2018 to know the prevalence of osteoporosis in Iraqi menopausal women. A total of the (88) women involved in this study, blood samples had been taken from the (68) osteoporosis menopausal women, and from (20) women who were apparently healthy as a control group. Assays of study estimation of the parameters levels that include: Calcium, phosphorous were done by using auto biochemistry analyzer; Receptor activator of nuclear factor NF-κB ligand bone alkaline phosphatase, Resistin and estrogen, were measurement by using a solid phase enzyme-linked immunosorbent assay (ELISA). Result: The result of study showed a significant decrease (p < 0.05) in concentration of serum estrogen, calcium and phosphorus in menopausal women with osteoporosis compared with healthy group. The biomarker revealed a significant increase (p < 0.05) in the concentration of receptor activator of nuclear factor NF-κB ligand and Resistin in menopausal women with osteoporosis compared with healthy group. The study exhibited correlation coefficient and showed a significant (p < 0.05) negative correlation between BMD and receptor activator of nuclear factor NF-κB ligand. The study showed a significant negative (p < 0.05) correlation between estrogen and of nuclear factor NF-κB ligand. This study show significant (p < 0.05) positive correlation of receptor activator of nuclear factor NF-κB ligand with resistin.
机译:骨质疏松症(OP)是骨磁性抑制症,其特征在于骨矿物密度(BMD)降低,并且由于骨骼结构的恶化导致自发性骨折。目前研究的目的是评估生物标志物包括;核因子NF-κB配体和抵抗力的受体激活剂,也测量生化包括:雌激素,钙,磷,骨密度,骨疏松症的绝经妇女中的T谱,进一步研究这些生物标志物与生化之间的相关性。方法:本研究在Al-Najaf省/伊拉克的Al-Sader教学医院放射学部门的德克萨(双能X射线吸收术)单位,从2018年1月至2018年7月,了解伊拉克绝经妇女骨质疏松症的患病率。参与本研究的(88)妇女共有(88)妇女,血液样本已从(68)骨质疏松症绝经妇女中,来自(20)妇女从(20)是作为对照组的妇女。研究估计的分析包括:通过使用自动生物化学分析仪进行钙,磷的参数水平;核因子NF-κB配体骨碱性磷酸酶,抗胰酶和雌激素的受体活化剂是通过使用固相酶联免疫吸附试验(ELISA)的测量。结果:与健康组相比,研究的血清雌激素,钙和磷的血清雌激素,钙和磷的浓度显着降低(P <0.05)。生物标志物在核因子NF-κB配体的核因子NF-κB配体的浓度下显示出显着增加(P <0.05),与健康组相比,骨疏松症的绝经妇女含量抗毒素。该研究表现出相关系数,核因子NF-κB配体的BMD和受体活化剂之间存在显着(P <0.05)的负相关性。该研究显示雌激素和核因子NF-κB配体之间的显着负(P <0.05)相关性。该研究显示出核因子NF-κB配体受体活化剂的显着(P <0.05)阳性相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号